ONUREG (azacitidine) for the Treatment of Acute Myeloid Leukaemia (AML)

ONUREG® (azacitidine) is the first and only FDA-approved continuing therapy recommended for adult patients with acute myeloid leukaemia (AML). Credit: Bristol Myers Squibb.



  • ONUREG (azacitidine)
  • ONUREG (azacitidine)
  • ONUREG (azacitidine)